Insider Cluster (2 insiders) ·Filed Jun 2, 2026

ASND

Ascendis Pharma A/S
BULLISH
Impact 4/10
Horizonweeks Processed4mo ago
Insider cluster: 2 insiders, $67K total
Actionable Insight ▲ Bullish

The cluster is too small to drive stock price action on its own, but CFO buying alongside a director signals management's confidence ahead of upcoming catalysts (likely TransCon PTH data or Skytrofa updates). Monitor for additional insider purchases or a material 8-K in the next 2-4 weeks. The historical calibration shows ASND insider-buy signals have underperformed (avg T+20 alpha -7.3%), so treat this as a modest positive signal, not a trade trigger.

DirectionBullish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
ASND ▲ +15.02% at T+60d
LONG call ✓ call won +15.02% · α vs SPY +12.53% · entry $216.79 → $249.36
Entry anchored
Jun 2, 2026
via day open
T+1d
+0.95%
call +0.95% · α +0.55%
$218.84
settled 4mo ago
T+5d
-3.23%
call -3.23% · α +0.59%
$209.79
settled 4mo ago
T+20d
+26.62%
call +26.62% · α +27.62%
$274.50
settled 3mo ago
T+60d
+15.02%
call +15.02% · α +12.53%
$249.36
settled 5w ago

Price Chart

Loading chart...

Executive Summary

CFO Scott Thomas and Director Jean-Jacques Bienaimé made open-market purchases totaling $67K over a 5-day window. While the dollar amount is trivial relative to ASND's $13.6B market cap (0.0005%), cluster buys — especially involving C-suite — carry asymmetric informational weight per the academic literature. The purchases occurred without any accompanying 10b5-1 pattern, suggesting voluntary conviction.

Key Financial Metrics

Direction
buying
Total Value
$122.5K
Insiders
2

Key Facts

  • CFO Scott Thomas purchased 350 shares total ($77.7K) across two separate open-market transactions on May 29 and June 2.
  • Director Jean-Jacques Bienaimé purchased 200 shares ($44.8K) on May 29.
  • Total cluster value of $122.5K is 0.0009% of ASND's $13.6B market cap — well below the 0.1% materiality threshold.
  • No 10b5-1 plan or vesting-driven pattern detected; both transactions are voluntary open-market buys.
  • ASND has 96% analyst bullish consensus (23 of 24 analysts at Buy/Strong Buy).

Financial Impact

Total insider purchases of $122.5K represent ~0.0009% of market cap — economically trivial in absolute terms.

insider ownership

Risk Factors

  • Historical calibration shows ASND insider-buy signals have delivered negative average alpha at T+20 (-7.3% vs SPY).
  • Dollar amount is too small to overcome the company's $13.6B market cap — institutional flows dominate.
  • No accompanying corporate event (earnings, pipeline update) to contextualize the buying.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
96% bullish (24 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ASND-1780431963004
29 reports for ASND
Performance horizon
84% Hit rate 16 of 19 directional calls best @ T+60▲ +24.50%Apr 7, 2026
Filters
Rows
Reports for ASND — sortable, filterable
TypeNow
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 2/10
$260.81 $247.69▼ −5.03%▼ −4.37%$227.23 (−12.88%)
Aug 31, 2026
4w ago
6-K
NEUTRAL ★ 6/10
$260.25 $260.81▲ +0.22%▲ +0.13%$227.23 (−12.69%)
Aug 27, 2026
5w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$249.36 $271.12▲ +8.73%▲ +8.46%$227.23 (−8.87%)
Aug 19, 2026
6w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$259.62 $250.25▼ −3.61%▼ −3.22%$227.23 (−12.48%)
Aug 19, 2026
6w ago
Insider Buy
NEUTRAL ★ 3/10
$259.62 $250.25▼ −3.61%▼ −3.22%$227.23 (−12.48%)
Aug 13, 2026
7w ago
6-K
BULLISH ★ 7/10
$246.23 $254.81▲ +3.48%▲ +5.45%$227.23 (−7.72%)
Aug 13, 2026
7w ago
Press Release
BULLISH ★ 7/10
$246.23 $254.81▲ +3.48%▲ +5.45%$227.23 (−7.72%)
Aug 6, 2026
8w ago
6-K
BULLISH ★ 7/10
$249.85 $246.23▼ −1.45%▼ −2.66%$227.23 (−9.05%)
Aug 6, 2026
8w ago
Press Release
BULLISH ★ 7/10
$249.85 $246.23▼ −1.45%▼ −2.66%$227.23 (−9.05%)
Jul 15, 2026
11w ago
6-K
NEUTRAL ★ 2/10
$259.80 $252.66▼ −2.75%▼ −1.08%$227.23 (−12.54%)
Showing 10 of 29

US Market Status

Market Open — Closes in 3h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 2, 2026